tiprankstipranks
Biogen price target raised to $313 from $275 at Barclays
The Fly

Biogen price target raised to $313 from $275 at Barclays

Barclays analyst Carter Gould raised the firm’s price target on Biogen to $313 from $275 and keeps an Equal Weight rating on the shares. There are some points for debate "around the edges," but full data presentation of the lecanemab Clarity AD study "should further de-risk approval," Gould tells investors in a research note. The analyst says investor focus is likely to shift toward commercial aspects going forward.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on BIIB:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles